ABSTRACT: Introduction: Sepsis-induced myopathy and critical illness myopathy are common causes of muscle weakness in intensive care patients. This study investigated the effect of different mean arterial blood pressure (MAP) levels on muscle membrane properties following experimental sepsis. Methods: Sepsis was induced with fecal peritonitis in 12 of 18 anesthetized and mechanically ventilated pigs. Seven were treated with a high (75-85 mmHg) and 5 were treated with a low (60 mmHg) MAP target for resuscitation. In septic animals, resuscitation was started 12 h after peritonitis induction, and muscle velocity recovery cycles were recorded 30 h later. Results: Muscles in the sepsis/high MAP group showed an increased relative refractory period and reduced early supernormality compared with the remaining septic animals and the control group, indicating membrane depolarization and/or sodium channel inactivation. The membrane abnormalities correlated positively with norepinephrine dose. Discussion: Norepinephrine may contribute to sepsis-induced abnormalities in muscle by impairing microcirculation.
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Intensive care unit (ICU)-acquired weakness is a frequent complication in critically ill patients. [1] [2] [3] [4] Typically, patients become symptomatic with generalized muscle weakness and failure to wean from mechanical ventilation. ICU-acquired weakness is often caused by sepsis-induced myopathy, critical illness myopathy (CIM), or a combination of these and other entities. 5 Sepsis, systemic inflammatory response syndrome, and multiple organ failure have been identified as important risk factors for ICU-acquired muscle pathologies. 1 Multiple mechanisms have been proposed, such as impaired microcirculation with consecutive bioenergetic failure, 1, 5 toxic action of cytokines, 1, 3, 5 disturbances of electrolyte gradients, [6] [7] [8] and muscle catabolism. [9] [10] [11] [12] [13] Furthermore, it has been shown that, during sepsis, muscle membrane potential changes occur.
14-17 Using a pig model, we demonstrated that muscle membrane abnormalities consistent with membrane depolarization and/or sodium channel inactivation occurred within 6 h of sepsis induced by fecal peritonitis. 18 Similar changes were found in patients diagnosed with probable CIM. 6 Muscle membrane properties can be assessed in vivo by recording multifiber muscle velocity recovery cycles (MVRC). Using direct muscle stimulation, a cluster of muscle fibers are excited with paired stimuli separated by an interstimulus interval (ISI) that is varied between 2 and 1,000 ms. The conduction velocity of the second action potential depends on the ISI. [19] [20] [21] [22] [23] This allows measurement of the muscle relative refractory period (MRRP) and early supernormality (ESN). Both measures are sensitive to muscle membrane potential and muscle ion channel function. In the early phase of septic myopathy and in probable CIM, a prolongation of MRRP and a reduction of ESN were found, indicating that muscle membranes were depolarized and/or that muscle sodium channel inactivation was increased. 6, 18 One possible pathophysiological mechanism for development of ICU-acquired muscle weakness is reduction of microcirculation, causing bioenergetic failure, eventually leading to ischemic muscle fibre injury. Under physiological conditions, blood flow autoregulation maintains organ perfusion constant in the face of changing perfusion pressure. If autoregulation is impaired either by a drop of systemic perfusion pressure below a critical value or by failure of regulatory mechanisms, organ ischemia can occur. There is an ongoing debate about optimal blood pressure management during sepsis. 24 The Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008 recommends vasopressors to achieve and maintain a mean arterial blood pressure (MAP) of at least 65 mmHg in patients who are not responding to initial fluid resuscitation. 25 Thereby, vasopressors variably affect systemic, regional, and organ perfusion. [26] [27] [28] The present study sought to evaluate the impact of 2 different MAP target levels on muscle membrane properties in an experimental model of sepsis induced by fecal peritonitis.
MATERIALS AND METHODS
Here we report data from 2 different studies in which neurophysiological measurements were carried out. Both studies were performed in accordance with the National Institute of Health guidelines for care and use of experimental animals and with the approval of the Animal Care Committee of the Canton of Bern, Switzerland (No. BE 88/ 09 and BE 70/10). The course of the disease, including hemodynamics and mitochondrial function, and aspects of resuscitation have been published previously. 29, 30 Animal Preparation. Animal preparation has been previously described in detail. 29, 30 In brief, 18 domestic pigs (mean weight 6 SD, 39.4 6 4.1 kg) were fasted overnight for 12 h and intramuscularly premedicated with ketamine (20 mg/kg) and xylazine (2 mg/kg) before induction of anesthesia with midazolam (0.5 mg/kg) and atropine (0.02 mg/kg), followed by orotracheal intubation. Anesthesia was maintained throughout the experiment with continuous intravenous infusions of propofol (4 mg/kg/h) and fentanyl (5 lg/kg/h during surgery and 2 lg/kg/h afterward). When required, additional boluses of midazolam (5 mg) and fentanyl (50 lg) were administered. Neuromuscular blocking agents were not used. Animals were ventilated in a volume-controlled mode with a positive endexpiratory pressure of 5 cm H 2 O, a fraction of inspired oxygen of 0.3, and a tidal volume of 8 ml/kg (Servo-i; Marquet Critical Care, Solna, Sweden). The respiratory rate was adjusted by targeting an arterial CO 2 partial pressure (PaCO 2 ) of 35-45 mmHg. A combination of Ringer's lactate and glucose 50% solutions was infused continuously and adjusted to maintain blood glucose in the range of 3.5-5 mmol/L. Up to 6 h was allowed for hemodynamic stabilization. Afterward, peritonitis was induced in 12 pigs by installation of 2 g/kg of autologous feces dissolved in 200-250 ml (37 8C) 5% glucose solution into the abdominal cavity. Six animals served as nonseptic controls.
Resuscitation was started 12 h after untreated sepsis and lasted for 48 h. Afterward, the animals were deeply sedated and killed with an overdose of potassium chloride. During resuscitation, all animals received intravenous antibiotic treatment with piperacillin-tazobactam (2.25 g) every 8 h and deep venous thrombosis prophylaxis with a continuous infusion of nonfractionated heparin (10,000 IU/24 h). In series 1, 29 resuscitation was targeted at MAP 60 mmHg (in both septic [n 5 5] and control animals [n 5 6]), and, in series 2, 30 resuscitation was targeted at MAP 75-85 mmHg (sepsis/high MAP group; n 5 7).
Animal Monitoring, Biological Data, and Resuscitation
Strategies. The following parameters were monitored continuously: hemodynamics, temperature and respiratory parameters (S/5 critical care monitor; Datex-Ohmeda, GE Healthcare, Helsinki, Finland), continuous thermodilution cardiac output (L/min), and mixed venous oxygen saturation (SvO 2 ; Vigilance; Edwards Lifescience, Irvine, CA). Data were recorded in data acquisition and signal analysis software (Soleasy; National Instruments, Austin, TX) and in an electronic patient data management system (Centricity; GE Healthcare).
Blood samples including arterial blood gas analysis were taken at the end of the stabilization period and immediately after the electrophysiological investigations. Sodium, potassium, glucose, lactate, pH, bicarbonate, and base excess were measured. Arterial blood samples were analyzed in a blood gas analyzer (GEM Premier 3000; Instrumentation Laboratory, Bedford, MA), for PaO 2 , PaCO 2 (adjusted to central body temperature), pH, lactate, bicarbonate, base excess, sodium, and potassium.
Hemodynamic Protocol. Additional fluid boluses and vasoactive drugs were administered according to a previously published hemodynamic protocol. 29, 30 Briefly, fluid boluses of 150 ml Ringer's lactate and 6% hydroxyethyl starch (130/0.4) were administered when pigs were hypovolemic and stroke volume had increased by more than 10% after the preceding administration. The maximal infused dose of hydroxyethyl starch was limited to 30 ml/kg; afterward, only Ringer's lactate was administered. If mixed SvO 2 was lower than 50%, dobutamine administration was started (5 mg/h) and was increased by 5 mg/h every 30 min until SvO 2 became 50% or the maximal dose of 20 mg/h was reached. When MAP was lower than the targeted resuscitation MAP, norepinephrine administration was started.
Recording of Multifiber MVRCs. MVRCs were recorded approximately 48 h after induction of anesthesia (corresponding to 42 h after induction of peritonitis in the animals with sepsis) by using a recently described protocol. 18, 21 In brief, multifiber responses to direct muscle stimulation were recorded on the foreleg from the extensor digitorum muscle. Stimulation currents were delivered through an insulated monopolar needle electrode (TECA; VIASYS Healthcare, Madison, WI) used as a cathode; a nonpolarizable surface electrode (Red Dot; 3M Health Care, Borken, Germany) served as an anode. The monopolar stimulation needle was inserted perpendicularly into muscle about 15 mm distally to the anode. Stimulus waveforms (rectangular current pulses of 0.05-ms duration) generated by a computer were converted to current with an isolated linear bipolar-current stimulator (DS 5; Digitimer Ltd, Welwyn Garden City, Hertfordshire, United Kingdom). Muscle compound action potentials were recorded within the same muscle by means of a 30G EMG electrode (Medtronic, Skovlunde, Denmark) inserted approximately 20 mm proximal to the stimulating needle. A nonpolarizable surface electrode served as a ground electrode and was taped to the shoulder of the animal.
The signal was amplified (gain 1,000, bandwidth 1.6-10 kHZ) and digitized (NI DAQCARD-6062E; National Instruments Europe, Debrecen, Hungary) by using a sampling rate of 20 kHZ. Stimulation and recording were controlled by QTRAC software (Institute of Neurology, University College London, London, United Kingdom).
Multifiber MVRCs with single conditioning stimuli, 2 test stimuli 10 ms apart, and test stimuli alone were recorded. The ISI between the conditioning stimulus and the test stimulus was varied from 1,000 to 1.4 ms in 34 steps in an approximately geometric series. Data analysis has been described in detail in previous papers. 21, 23 From each MVRC we assessed (1) relative refractory period, measured as the interpolated ISI at which the response latency first recovered to its unconditioned value; (2) ESN, measured as the peak percentage reduction in latency at ISIs shorter than 15 ms; (3) late supernormality, measured as the mean percentage reduction in latency at ISIs between 50 and 150 ms; and (4) extra late supernormality, measured as the increase in late supernormality due to a second conditioning stimulus.
Statistical Analysis. Statistical analyses were performed in the QTRAC data analysis software (Institute of Neurology, University College London), which was also used to generate the figures. Hemodynamic data, laboratory results, and MVRC parameters of the control, sepsis, and sepsis/ high MAP groups were compared by using the KruskalWallis test. To test for differences between the 2 treatment groups (sepsis and sepsis/high MAP), the Mann-Whitney U test was used. Correlations between MVRC measures and treatment and other measurements were tested by Spearman's q.
RESULTS
Clinical Measurements. Characteristics of the 3 groups (controls, sepsis, and sepsis/high MAP) are summarized in Table 1 . Forty-two hours after induction of peritonitis (30 h after initiating the different methods of resuscitation), the sepsis/ high MAP group had achieved MAP values of 82 6 4 mmHg, and the sepsis group had achieved MAP values of 71 6 8 mmHg (P 5 0.03). Norepinephrine was administered to all animals in the sepsis/high MAP group and to 2 of 5 animals in the sepsis group. Apart from difference in MAP and a small (0.4 8C) difference in core temperature, none of the other nonelectrophysiological measurements differed significantly between sepsis and sepsis/high MAP groups (Table  1) .
MVRCs. Results of electrophysiological investigations are shown in Figure 1 and Table 2 . After 30 h of resuscitation, MVRCs of animals of the sepsis/ high MAP group were shifted to the right and upward compared with MVRCs of animals of the sepsis group, indicating membrane depolarization and/or sodium channel inactivation. This shift corresponded to a significant prolongation of the relative refractory period and a significant reduction in ESN compared with the sepsis group ( Fig. 2A,B , Table 2 ). The late supernormality and extra late supernormality were not significantly affected by the sepsis.
To investigate the cause of the differences in MRRP and ESN between the sepsis/high MAP and sepsis groups, these values were correlated separately with the measurements in Table 1 for the whole group of 12 animals with sepsis (Table 3) . This shows that, despite the significant differences in muscle membrane properties between the sepsis/high MAP and sepsis groups, there was no significant correlation between individual muscle excitability and MAP measurements. The muscle differences between groups cannot therefore be attributed to MAP alone. The strongest correlations between MRRP and peak ESN were observed with lactate levels and the total amount of norepinephrine injected (Table 3) . Mean fluid balance 5 (Ringer's lactate basal infusion 1 glucose 50% basal infusion 1 Ringer's lactate bolus 1 hydroxyethyl starch bolus) -(urine output 1 gastric tube output).
*P values comparing sepsis and sepsis/high MAP groups (Mann-Whitney U test).
DISCUSSION
After 30 h of resuscitation, muscle excitability testing demonstrated a significant increase of refractoriness paralleled by a significant reduction in supernormality in the sepsis/high MAP compared with the sepsis group. These changes in muscle excitability measurements correlated positively with the cumulative dose of norepinephrine administered during resuscitation.
Muscle excitability testing provides an assessment of muscle fiber properties that does not depend on nerve function or neuromuscular transmission. [19] [20] [21] 23, 31 This method was previously used to study the early phase of septic myopathy in a porcine model of peritonitis with consecutive sepsis over a period of 27 h. 18 Muscle membrane dysfunction was found to occur within 6 h of experimental sepsis. Furthermore, similar muscle membrane dysfunction was shown in patients with probable CIM in the chronic state, 6 in which it provided evidence that membrane depolarization and/or sodium channel inactivation occurs.
We have found similar changes of the 2 main parameters of muscle membrane excitability measurements (prolongation of refractory period and reduction of ESN) during experimental limb ischemia in healthy volunteers 21 and hypothesized that these findings are related to a dysfunction of the Na 1 /K 1 pump with consecutive cell membrane depolarization. Impaired microcirculation has already been postulated to be a factor in the development of myopathy in critical ill persons. 1, 5 Theoretically, one would expect that an increase of MAP would result in a better organ perfusion if blood flow autoregulation were impaired, or unaffected organ perfusion if autoregulation were sustained. Vasopressors have been shown to variably affect systemic, regional, and organ perfusion. [26] [27] [28] For example, in patients with septic shock, sublingual microcirculatory alterations did not improve in response to an increase of MAP with norepinephrine. 32 Furthermore, linear trend analysis demonstrated reductions in the capillary and in the perfused capillary densities. 32 We found a positive correlation between the cumulative dose of norepinephrine (but not of achieved blood pressure) and muscle membrane alterations, possibly related to a norepinephrine-induced reduction of microcirculation leading to ischemia in the muscle. The strong correlation between muscle membrane changes and lactate (but not pH) supports the idea that the membrane changes were related to ischemia, with a resultant switch to anaerobic glycolysis. This hypothesis is also supported by the findings of a recent clinical observational study that demonstrated that the required amount of catecholamine was a risk factor for the development of impaired direct muscle stimulation. 33 In contrast to our finding of norepinephrine-related muscle membrane depolarization, earlier studies have shown that, in isolated muscles, catecholamines stimulate the Na 1 /K 1 pump and cause cell membrane hyperpolarization. [34] [35] [36] This difference might be explained by the hypothesis that, in vivo, the norepinephrine-induced hypoperfusion of the muscle capillaries with consecutive energy depletion and dysfunction of the muscle Na 1 /K 1 pump overweighs the direct hyperpolarizing effect of norepinephrine on the muscle cell membrane. However, we cannot exclude that muscle membrane depolarization is caused by other factors also (e.g., sepsis-related inflammatory mediators). 1, 3, 5 Because only the sepsis/high MAP group (and not the sepsis group) showed muscle membrane depolarization, we assume that these are of less importance for changes of muscle membrane potential. Furthermore, the strong correlation of muscle membrane excitability parameters with lactate supports the hypothesis that the membrane changes were related to norepinephrine-induced ischemia.
Our study has some limitations. First, it was not possible to blind the investigators to the treatment regime during the resuscitation phase. Because we used well-defined treatment protocols, we think that this did not cause a bias. Second, we cannot provide microcirculation parameters. However, the numerically lower systemic perfusion in the sepsis/high MAP compared with the sepsis group (<80%) together with the massively higher doses of norepinephrine used supports the concept of diminished microcirculation in the former group. Our study was conducted in young pigs; the findings might have been different in adult animals or in human patients. Nevertheless, although critical illness polyneuropathy/myopathy is much less frequently described in pediatric compared with adult patients, 37 typical findings of the disease have been reported repeatedly in animals younger than our pigs. [38] [39] [40] Finally, our study findings can be related only to septic myopathy and not to CIM because the period of observation was too short. Also, we could detect neither MAP-target-dependent skeletal muscle adenosine triphosphate contents nor mitochondrial respiration abnormalities. Boxes and whiskers show median, interquartile range, and range. *P < 0.05, **P < 0.01, significant differences by Mann-Whitney U test. MAP, mean arterial blood pressure; NS, not significant.
In conclusion, our results suggest that administration of norepinephrine to elevate MAP during resuscitation may contribute to sepsis-induced abnormalities in muscle. This may be due to a norepinephrineinduced reduction of microcirculation, increasing the risk of ischemic muscle damage. Confirmation in humans is required. Ethical Publication Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
